NEW YORK, Nov. 28, 2012 /PRNewswire/ -- Reportlinker.com
announces that a new market research report is available in its
catalogue:
The Pharmaceutical Market: India
http://www.reportlinker.com/p0203061/The-Pharmaceutical-Market-India.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
Espicom's highly regarded world pharmaceutical market reports
have been redesigned to provide enhanced strategic intelligence in
a user-friendly format. Each report provides in-depth information,
setting the pharmaceutical market in context. The reports
provide:
Five-year projections for economic, demographic, health
expenditure, health workforce and pharmaceutical market
indicators.
Specialised intelligence on OTCs, generics, biologics and
biosimilars.
Exclusive economic and demographic data from the Economist
Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health
expenditure, health infrastructure, health services and health
personnel.
The reports are updated quarterly, providing you with the latest
information for a full year. In addition, the service will keep you
up to date with market and industry news on a regular basis.
TABLE OF CONTENTS
EXECUTIVE SUMMARY 1
Snapshot: Strategic Espicom Analysis 2
Snapshot: Key Data Projections3
MACROENVIRONMENT 4
POLITICAL 4
ECONOMIC5
Projections 5
LEGAL 6
Background to Pharmaceutical Patents 6
Mashelkar Committee Report, December
2006 6
The Patents (Amendments) Bill, 2005 7
Compulsory Licensing 7
Pre- & Post-Grant Opposition 8
Mailbox Applications 8
Other Issues 9
The Patents (Amendment) Rules, 2006 9
Previous Patents Act Amendments and Exclusive Marketing Rights
10
Challenges and Patent Decisions in the Indian High Courts 10
Novartis Once Again Challenges the Indian Patents Act 10
Bayer's Nexavar Patent Challenged by Compulsory Licence
Application 11
US Special 301 Report - India Remains on Priority Watch List
12
DEMOGRAPHIC 12
Population 12
Demographic Indicators 14
Births 14
Deaths 14
Infant Mortality 14
Life Expectancy at Birth 14
EPIDEMIOLOGY 16
DISEASE BURDEN 16
Leading Causes of Mortality 16
DISEASE PREVALENCE17
Communicable Diseases 17
HIV/AIDS 19
Leprosy20
Tuberculosis20
Vector Borne Diseases 21
Non-Communicable Diseases 21
Blindness 21
Cancer 21
Diabetes, Cardiovascular Disease and Stroke22
National Rural Health Mission22
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 24
ORGANISATION 24
Public Sector 24
Department of Health and Family Welfare 24
Department of AYUSH 25
Private Sector 25
Health Insurance 26
EXPENDITURE 27
Projections 27
Latest Figures 28
INFRASTRUCTURE 29
Hospital Infrastructure29
Private Hospitals and Clinics30
Apollo Hospitals Group 30
Fortis Healthcare 30
Max Healthcare 30
Wockhardt Hospitals30
Other Commercial Providers 31
Ambulatory Infrastructure31
Primary Care 31
First Aid and Disaster Relief 32
WORKFORCE 32
Projections 32
Latest Figures 33
REGULATORY AFFAIRS 35
NATIONAL AUTHORITY 35
REGULATORY DEVELOPMENTS 36
New Drug Advisory Committees36
MARKETING REGISTRATION 37
DGCI Set to Co-ordinate Drug Approvals 38
PROMOTION 38
PRICING 39
Drugs (Prices Control) Amendment Order and Second Amendment
Order, 2006 39
Draft National Pharmaceuticals Pricing Policy, 2011 40
DISTRIBUTION CHANNELS 42
Medical Stores Organisation 42
Pharmacy Chains 42
Apollo Pharmacy 42
Guardian Lifecare 42
Religare Wellness 42
98 4 42
MARKET ANALYSIS 43
SIZE 43
Projections 43
Historical Figures 46
Current Structure 47
PRODUCT DEVELOPMENT 48
Traditional Indian Medicines 49
MANUFACTURING 51
TRADE52
Exports 52
Imports 54
Balance of Trade 58
COMPETITION 59
Foreign Direct Investment in the Pharmaceutical Industry under
Review 59
TRADE ASSOCIATIONS 60
TRADE FAIRS 60
Bangalore Bio 201260
India Chem 2012 60
Pharma World EXPO 60
COMPANY INTELLIGENCE61
Foreign Private Producers 61
Abbott 61
Actavis 61
Bayer Healthcare 61
Daiichi Sankyo 62
GlaxoSmithKline 62
Mylan62
Pfizer India63
Reckitt Benkiser63
Sanofi63
Local Private Producers 64
Alembic Ltd 64
Aurobindo Pharma66
Cipla Ltd 68
Claris Lifesciences71
Dr Reddy's Laboratories Ltd 72
Glenmark Pharmaceuticals 75
Jubilant Life Sciences78
Lupin Limited 79
Natco Pharma 82
Orchid Chemicals & Pharmaceuticals Ltd 84
Piramal Healthcare 87
Ranbaxy Laboratories 89
Strides Arcolab 92
Sun Pharma 94
Torrent Pharmaceuticals97
Wockhardt Ltd 99
Zydus Cadila 102
COMPETITIVE STRATEGIES 106
Recent Acquisitions & Divestitures 106
Agreements 106
BIOLOGICS & BIOSIMILARS 108
COMPETITION 108
Company Intelligence108
Avesthagen 108
BCG Vaccine Laboratory, Chennai109
Biocon109
Cipla 111
Claris Lifesciences 111
Dr Reddy's111
Glenmark Pharmaceuticals 112
Lupin 112
Panacea Biotec 113
Ranbaxy/Daiichi Sankyo 113
Wockhardt 114
Zydus Cadila 114
COMPETITIVE STRATEGIES 115
CONCLUSIONS: OPPORTUNITIES & CHALLENGES 116
Strategic Espicom Analysis 116
MACROENVIRONMENT 116
EPIDEMIOLOGY 116
HEALTHCARE 117
REGULATORY AFFAIRS 117
PRICING & REIMBURSEMENT 117
DISTRIBUTION CHANNELS 118
MARKET 118
COMPETITION 118
OTC PHARMACEUTICALS 118
GENERICS 118
BIOLOGICS & BIOSIMILARS 119
Radar & SWOT Analysis 121
DIRECTORY 122
GOVERNMENT ORGANISATIONS 122
PHARMACEUTICAL COMPANIES 123
TRADE ASSOCIATIONS 123
List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012 2
Key Data Projections, 2012-2017 3
Political Landscape, 2012 4
Regional Ranking of Projected Economies, 2017 5
Projected Economy, 2012-2017 5
Regional Ranking of Projected Demographics, 2017 13
Projected Demographics, 2012-2017 13
Summary of Demographic Data 15
Demographic Indicators, 2000-2010 15
Deaths from Communicable Diseases, 2004-2009 16
Reported Incidence of Communicable Diseases, 2005-2009 17
Reported Incidence of Vaccine Preventable Diseases, 2008-2010
18
Regional Ranking of Projected Health Expenditure, 2017 27
Projected Health Expenditure, 2012-2017 27
Health Expenditure, 2011 28
Regional Ranking of Projected Physicians, 2017 32
Projected Physicians, 2012-2017 33
Doctors Registered with State Medical Councils, 2007-2010 33
Regional Ranking of Projected Pharmaceutical Markets, 2017
43
Asia Pacific Market Share, 2017 44
Projected Pharmaceutical Market at Retail Prices, 2012-2017
45
Historical Pharmaceutical Market at Retail Prices, 1995-2010
(US$ Million)46
Pharmaceutical Exports by Category, 1995-2010 (US$000s) 52
Pharmaceutical Exports by Country/Region, 2010 (US$000s) 53
Pharmaceutical Imports by Category, 1995-2010 (US$000s) 54
Imports of Raw Materials by Country/Region, 2010 (US$000s)
55
Imports of Antisera & Vaccines by Country/Region, 2010
(US$000s) 56
Imports of Medicaments by Country/Region, 2010 (US$000s) 57
Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 58
Foreign Acquisitions of Indian Pharmaceutical Companies,
2007-2011 59
Alembic: Financial Results, 2007-2011 64
Alembic: Manufacturing Facilities 65
Aurobindo Pharma: Financial Results, 2007-2011 66
Aurobindo Pharma: Manufacturing Facilities 67
Cipla: Financial Results, 2007-2011 68
Cipla: Manufacturing Facilities 70
Dr Reddy's: Financial Summary, 2007-2011 73 Dr Reddy's:
Manufacturing Facilities 74
Glenmark: Financial Results, 2007-2011 75
Glenmark: Manufacturing Facilities 77
Jubilant Life Sciences: Financial Results, 2010-2011 78
Lupin: Financial Results, 2007-2011 80
Lupin: Manufacturing Facilities 81
Natco Pharma Financial Results, 2007-2011 82
Orchid: Financial Results, 2007-2011 85
Orchid's Top-10 Brands 85
Orchid: Manufacturing Facilities 86
Piramal Healthcare: Financial Results, 2007-2011 87
Piramal Healthcare: Manufacturing Facilities 88
Ranbaxy: Financial Results, 2006-2010 89
Ranbaxy: Manufacturing Facilities 91
Strides: Financial Results, 2006-2010 92
Sun Pharma: Financial Results, 2007-2011 94 Sun Pharma:
Manufacturing Facilities 96
Torrent Pharma: Financial Results, 2007-2017 97
Wockhardt: Financial Results, 2006-2011 99 Wockhardt
Manufacturing Facilities 101
Zydus Cadila: Financial Results, 2007-2011 103
Zydus Cadila: Manufacturing Facilities 105
Biocon: Financial Results, 2007-2011 110
Panacea Biotec: Financial Results, 2007-2011 113
Espicom Analysis of the Pharmaceutical Market, 2012 120
SWOT Analysis of the Pharmaceutical Market, 2012 121
List of Charts
Population by Age Group (%)12
Regional Comparison of Top 5 Projected Pharmaceutical Markets at
Retail Prices, 2017 44
Regional Comparison of Projected Pharmaceutical Market Share,
2017 45
Historical Pharmaceutical Market at Retail Prices, 1995-2010
47
Pharmaceutical Exports, 1995-2010 (US$ Millions) 52
Pharmaceutical Imports, 1995-2010 (US$ Millions) 54
Pharmaceutical Imports by Country/Region, 2010 (%) 55
Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions) 58
Radar Graph of the Pharmaceutical Market, 2012 121
To order this report:
Pharmaceutical Industry: The Pharmaceutical
Market: India
Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker